在针对性口服抗癌药物治疗的前8周期间,患者的症状,信心和坚持
Amna Rizvi-Toner1,2, Antoinette B Coe3, Christopher R Friese4
1Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI, USA. arizvito@umich.edu.
概括
服用口服抗癌药物 (OAA) 的患者出现了严重的症状,但随着时间的推移,他们对管理这些症状的信心和对OAA的坚持有所改善. 识别症状-信心关系可以指导对OAA治疗的临床支持.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 患者报告的结果
背景情况:
- 向性口服抗癌剂 (OAAs) 越来越多地用于癌症治疗.
- 了解患者的经验,包括症状负担和自我管理,对于优化OAA治疗至关重要.
研究的目的:
- 调查患者对有针对性的OAAs的初始经验.
- 检查症状严重程度如何影响患者的信心和对OAA的坚持.
主要方法:
- 在OAA治疗的前8周内,对59名患者进行了长度前性队列研究.
- 患者报告的结果指标 (PROM) 在线收集在三个时间点.
- 统计分析包括描述性统计,物流回归和混合效应物流回归.
主要成果:
- 经常报告严重的症状,特别是疲劳和昏昏欲睡.
- 在为期8周的研究期间,患者对控制症状的信心在增加.
- 虽然大多数报告的坚持率高 (75-80%),但20-25%的坚持率低于最佳;信心与年龄有关,与症状严重程度相反.
结论:
- 在OAA治疗期间,对控制症状的信心有所改善,但严重症状仍然存在.
- 很大一部分患者表现出低于最佳的OAA坚持,尽管自我报告的坚持很高.
- 确定症状严重程度,信心和坚持之间的患者特定关系对于有针对性的临床支持至关重要.
相关概念视频
Oral Hypoglycemic Agents: Glinides
695
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
695
Oral Hypoglycemic Agents: Sulfonylureas
1.2K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
694
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
694
Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K
Confidence Coefficient
10.7K
The confidence coefficient is also known as the confidence level or degree of confidence. It is the percent expression for the probability, 1-α, that the confidence interval contains the true population parameter assuming that the confidence interval is obtained after sufficient unbiased sampling; for example, if the CL = 90%, then in 90 out of 100 samples the interval estimate will enclose the true population parameter. Here α is the area under the curve, distributed equally under...
10.7K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
597
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
597


